Clinical Trial

Optimisation of High Flow Oxygen Therapy Settings During Hypoxaemic Respiratory Distress Based on Non-contact Measurement of Lung Volumes by Depth Camera

Study acronym: DiStok
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to validate the interest of a strategy adjusting the flow rate delivered under high-flow oxygen (HFO) therapy according to the lung volumes measured by a new technique, in intensive care patients with hypoxemic respiratory distress (HRD). The main question it aims to answer is: "The use of a technique of measurement of lung pulmonary with adjustement to the flow rate can make it possible to limite intubation in patients with HRD in intensive care?" The participants will be the patients admitted in intensive care for HRD with the need for treatment with HFO. This participants will be randomized in : * the arm control: treated by high flow oxygen therapy according to standard procedures. * or in the experimental arm : treated by high flow oxygen therapy with adjustement of ventilatory parametres based on lung volume measurements, obtained by the depth camera.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-10.
Status change: Not Yet Recruiting → Recruiting 2026-06-25
Trial Details
NCT Number NCT06819644
Lead Sponsor University Hospital, Brest
Conditions Hypoxemic Respiratory Failure
Enrollment 406 participants
Start Date 2026-04-08
Primary Completion 2030-10 (estimated)
Study Completion 2030-10 (estimated)
Updated on ClinicalTrials.gov 2026-06-29